Stroke

Latest Features

Improving Stroke Diagnosis Accuracy: An Expert Interview

Improving Stroke Diagnosis Accuracy: An Expert Interview

An interview with David E. Newman-Toker, MD, PhD, on reducing the frequency of misdiagnoses.

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

Oral Anticoagulants After Intracranial Hemorrhage Reduced Mortality Risk in Afib

A declining trend in ischemic events was associated with oral anticoagulant therapy after intracranial hemorrhage.

VIDEO: AHA - Improving Patient Care in Stroke

VIDEO: AHA - Improving Patient Care in Stroke

AHA presents Laurie Paletz, stroke coordinator at Cedar-Sinai Medical Center in Los Angeles, describing her institution's experience using Get With the Guidelines-Stroke and Target: Stroke to improve patient care.

Transient Ischemic Attack Treatment Strategy Changes May Have Led to Lower CV Events Risk

Transient Ischemic Attack Treatment Strategy Changes May Have Led to Lower CV Events Risk

Risk for stroke and other vascular events at 90 days was 3.7% vs 12% to 20% in previous cohorts.

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Left Atrial Appendage Closure: Exciting New Proposition or a Practically Non-Feasible Alternative?

Occlusion of the left atrial appendage provides protection against thromboembolic stroke in patients with nonvalvular atrial fibrillation.

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Factors Affecting Choice of Non-Vitamin K Antagonist Oral Anticoagulants

Choosing the right anticoagulant agent can be a challenge for many reasons, including cost, familiarity, drug interactions, and reversibility.

Stroke Prevalence and Risk May Be Higher in Patients With Asymptomatic Atrial Fibrillation

Stroke Prevalence and Risk May Be Higher in Patients With Asymptomatic Atrial Fibrillation

Risk and prevalence of stroke in patients with undiagnosed asymptomatic atrial fibrillation remains problematic for patients and clinicians.

Guidelines for Management of Hypertension With Stroke Remain Unclear

Guidelines for Management of Hypertension With Stroke Remain Unclear

Guidelines for hypertension management during acute stroke are based on clinician experience.

Latest News

Proton-Pump Inhibitors Reduce Bleeding Risk in Antiplatelet Therapy

Proton-Pump Inhibitors Reduce Bleeding Risk in Antiplatelet Therapy

The risk for major bleeding while taking antiplatelet therapy significantly increased with age.

Pregnancy-Associated Stroke in Women With Preeclampsia

Pregnancy-Associated Stroke in Women With Preeclampsia

Women with preeclampsia have up to a 6-fold risk of pregnancy-associated stroke.

American Association for Thoracic Surgery Guidelines on Surgical Ablation for Atrial Fibrillation

American Association for Thoracic Surgery Guidelines on Surgical Ablation for Atrial Fibrillation

The American Association for Thoracic Surgery has developed evidence-based guidelines on the use of surgical ablation for atrial fibrillation.

Testosterone Use Leads to Adverse Cerebrovascular Event: A Case Study

Testosterone Use Leads to Adverse Cerebrovascular Event: A Case Study

A cerebrovascular event in a young, healthy, male patient was found to be associated with the use of exogenous testosterone.

Left Atrial Appendage Isolation for Stable Sinus Rhythm

Left Atrial Appendage Isolation for Stable Sinus Rhythm

Although stable sinus rhythm was achieved in some patients after LAA isolation, embolic stroke and LAA thrombus formation was still problematic.

Both Genders Have Increased Stroke Risk With Elevated Serum Uric Acid

Both Genders Have Increased Stroke Risk With Elevated Serum Uric Acid

Researchers found no indication of gender-specific effects of elevated serum uric acid levels on stroke risk.

Endovascular Treatment for Acute Ischemic Stroke Shows Benefits at 2 Years

Endovascular Treatment for Acute Ischemic Stroke Shows Benefits at 2 Years

The response to endovascular treatment for acute ischemic stroke after 2 years was as good as in the first 90 days.

Cardiovascular Events in Hypogonadism May Be Reduced With Testosterone Therapy

Cardiovascular Events in Hypogonadism May Be Reduced With Testosterone Therapy

Testosterone replacement therapy may show a protective effect against myocardial infarction and stroke in men with secondary hypogonadism.

Stroke Patients with Increased Body Weight Benefit from IV tPA

Stroke Patients with Increased Body Weight Benefit from IV tPA

A fixed dose of 90 mg of intravenous tissue plasminogen activator is efficient for ischemic stroke in patients weighing over 100 kg.

Stroke and MI Rates Have Decreased Since Trans Fatty Acid Restrictions Enacted

Stroke and MI Rates Have Decreased Since Trans Fatty Acid Restrictions Enacted

Compared with New York counties without trans fatty acid restrictions, those with restrictions showed a significantly greater decline in combined myocardial infarction and stroke events.

Sign Up for Free e-Newsletters